Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort
- PMID: 12911554
- DOI: 10.1046/j.1523-1755.2003.00185.x
Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort
Abstract
Background: Autosomal-dominant polycystic kidney disease (ADPKD) is characterized by gradual renal enlargement and cyst growth prior to loss of renal function. Standard radiographic imaging has not provided the resolution and accuracy necessary to detect small changes in renal volume or to reliably measure renal cyst volumes. The Consortium for Radiologic Imaging Studies in Polycystic Kidney Disease (CRISP) is longitudinally observing ADPKD individuals using high-resolution magnetic resonance (MR) imaging to determine if change in renal and cyst volumes can be detected over a short period of time, and if they correlate with decline in renal function early in disease.
Methods: Standardization studies were conducted in phantoms and four subjects at each participating clinical center. After, in the full-scale protocol, healthy ADPKD individuals 15 to 45 years old with creatinine clearance>70 mL/min underwent standardized MR renal imaging, renal iothalamate clearance, comprehensive clinical evaluation, and determination of 24-hour urinary albumin and electrolyte excretion. Stereology was used from T1-weighted images to quantify renal volume, and region-growing thresholding was used from T2-weighted images to determine cyst volume. Renal structures were evaluated in relation to demographic, clinical, and biochemical variables using means/medians, standard deviations, and Pearson correlations.
Results: Reliability coefficients for MR renal and cyst volume measurements in phantoms were 99.9% and 89.2%, respectively. In the full-scale protocol, 241 ADPKD individuals (145 women and 96 men) were enrolled. Total renal, cyst, and % cyst volume were significantly greater in each decade group. Hypertensive individuals demonstrated greater renal, cyst, and % cyst volume than normotensive subjects. Age-adjusted renal (r = -0.31, P < 0.0001), cyst (r = -0.36, P < 0.0001), and % cyst volume (r = -0.35, P < 0.0001) were inversely related to glomerular filtration rate (GFR). Age-adjusted renal volume (r = 0.42, P < 0.0001), cystic (r = 0.39, P < 0.0001, and % cyst volume (r = 0.41, P < 0.0001) were related with urinary albumin excretion.
Conclusion: MR measures of renal and cyst volume are reliable and accurate in patients with ADPKD. ADPKD is characterized by significant cystic involvement that increases with age. Structure (renal and cyst volume) and function (GFR) are inversely related and directly related with the presence of hypertension and urinary albumin excretion in individuals with normal renal function.
Similar articles
-
Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney disease.Kidney Int. 2003 Dec;64(6):2214-21. doi: 10.1046/j.1523-1755.2003.00326.x. Kidney Int. 2003. PMID: 14633145
-
Reliability of magnetic resonance imaging for measuring the volumetric indices in autosomal-dominant polycystic kidney disease: correlation with hypertension and renal function.Nephron Clin Pract. 2006;103(4):c173-80. doi: 10.1159/000092915. Epub 2006 Apr 24. Nephron Clin Pract. 2006. PMID: 16636585
-
Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function.Am J Kidney Dis. 2015 Jun;65(6):833-41. doi: 10.1053/j.ajkd.2014.11.010. Epub 2015 Jan 15. Am J Kidney Dis. 2015. PMID: 25600953
-
Approaches to testing new treatments in autosomal dominant polycystic kidney disease: insights from the CRISP and HALT-PKD studies.Clin J Am Soc Nephrol. 2008 Jul;3(4):1197-204. doi: 10.2215/CJN.00060108. Epub 2008 Jun 25. Clin J Am Soc Nephrol. 2008. PMID: 18579674 Review.
-
Current diagnostic evaluation of autosomal dominant polycystic kidney disease.Pol Arch Med Wewn. 2008 Dec;118(12):767-73. Pol Arch Med Wewn. 2008. PMID: 19202957 Review.
Cited by
-
Total kidney volume in autosomal dominant polycystic kidney disease: intraobserver and interobserver agreement of two methods with MRI.Turk J Med Sci. 2024 Jan 5;54(3):537-544. doi: 10.55730/1300-0144.5820. eCollection 2024. Turk J Med Sci. 2024. PMID: 39049998 Free PMC article.
-
Visceral Adiposity and Progression of ADPKD: A Cohort Study of Patients From the TEMPO 3:4 Trial.Am J Kidney Dis. 2024 Sep;84(3):275-285.e1. doi: 10.1053/j.ajkd.2024.02.014. Epub 2024 Apr 10. Am J Kidney Dis. 2024. PMID: 38608748 Clinical Trial.
-
Kidney Stones Account for Increased Imaging Studies in Autosomal Dominant Polycystic Kidney Disease.Kidney360. 2024 May 1;5(5):707-714. doi: 10.34067/KID.0000000000000424. Epub 2024 Mar 25. Kidney360. 2024. PMID: 38526140 Free PMC article.
-
Real-life use of tolvaptan in ADPKD: a retrospective analysis of a large Canadian cohort.Sci Rep. 2023 Dec 14;13(1):22257. doi: 10.1038/s41598-023-48638-9. Sci Rep. 2023. PMID: 38097698 Free PMC article.
-
Predicting autosomal dominant polycystic kidney disease progression: review of promising Serum and urine biomarkers.Front Pediatr. 2023 Nov 10;11:1274435. doi: 10.3389/fped.2023.1274435. eCollection 2023. Front Pediatr. 2023. PMID: 38027263 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical